Survival statistics for childhood Ewing sarcoma of the bone

Last medical review:

Survival statistics for childhood Ewing sarcoma of the bone are very general estimates and must be interpreted very carefully. These statistics are based on the experience of groups of children and cannot be used to predict a particular child’s chances of survival.

There are many different ways to measure and report cancer survival statistics. Your child’s doctor can explain the statistics for childhood Ewing sarcoma of the bone and what they mean for your child.

Observed survival

Observed survival is also called overall survival. It is the percentage of children with a certain type of cancer who are expected to live for at least a specified period of time after their diagnosis. Doctors often use the observed survival rate when they talk about a prognosis.

The 5-year observed survival for Ewing sarcoma of the bone in children 0 to 14 years of age is 79%. This means that, on average, 79% of children diagnosed with Ewing sarcoma of the bone are expected to live at least 5 years after their diagnosis.

Survival by stage

Survival varies with each stage of childhood Ewing sarcoma of the bone. Generally, the earlier Ewing sarcoma of the bone is diagnosed and treated, the better the outcome.

There are no specific Canadian statistics available for the different stages of Ewing sarcoma of the bone in children. The following information comes from a variety of sources. It may include statistics from other countries that are likely to have similar outcomes as in Canada.

Childhood Ewing sarcoma of the bone cancer survival


5-year observed survival




20% to 39%

Questions about survival

Talk to the doctor about prognosis. Prognosis depends on many factors, including:

  • the type of cancer
  • the stage
  • certain characteristics of the cancer
  • the treatments chosen
  • how the cancer responds to treatment

Only a doctor familiar with these factors can put all of this information together with survival statistics to arrive at a prognosis.

Expert review and references

  • Abha Gupta, MD, MSc, FRCPC
  • Raveena Ramphal, MBChB, FRACP

Medical disclaimer

The information that the Canadian Cancer Society provides does not replace your relationship with your doctor. The information is for your general use, so be sure to talk to a qualified healthcare professional before making medical decisions or if you have questions about your health.

We do our best to make sure that the information we provide is accurate and reliable but cannot guarantee that it is error-free or complete.

The Canadian Cancer Society is not responsible for the quality of the information or services provided by other organizations and mentioned on, nor do we endorse any service, product, treatment or therapy.

1-888-939-3333 | | © 2024 Canadian Cancer Society